Cancer Cell Membrane‐Coated Nanoparticles for Homotypic Targeting and Photothermal Chemo‐Immunomodulatory Therapy of Oral Cancer
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Shishira P S und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanomedicine Research Laboratory, Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Telangana, India. Hauptthemen laut MEDLINE: Nanoparticles, Mouth Neoplasms, Cell Membrane, Photothermal Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
The integration of chemotherapeutics with photothermal immunomodulatory strategies, leveraging a nanotechnology platform, has transformative potential for cancer therapy. In this context, we have designed a novel biomimetic platform by cloaking Palbociclib‐loaded mesoporous silica‐polypyrrole nanoparticles with homologous cancer cell membranes (CM@SP‐PLB NPs). These biomimetic NPs exhibit optimal physicochemical characteristics, including uniform morphology, laser‐responsive drug release, and a photothermal efficiency of 57.6%. In vitro assays demonstrate enhanced homotypic cellular uptake, reactive oxygen species (ROsS) generation, mitochondrial dysfunction, and potent cytotoxicity in human and murine oral cancer cells. Additionally, they induce the release of immunogenic cell death (ICD) markers via exposure of the surface marker calreticulin (CALR) and extracellular ATP release. CM@SP‐PLB NPs (+L) exhibited superior tumor accumulation, photothermal effects, and increased temperature up to 55°C, resulting in effective tumor volume regression. In vivo immunomodulation studies showed tumor‐associated macrophage repolarization and significant immunomodulatory reprogramming by downregulating immunosuppressive markers while markedly upregulating key pro‐inflammatory and antitumor immune genes, thereby enhancing the antitumor immune response. Furthermore, systemic biocompatibility and reduced metastasis further substantiate the nanoplatform's therapeutic potential. Overall, the developed bioinspired nanoplatform offers a chemo‐immunomodulatory photothermal strategy for synergistic eradication of tumors in oral cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanomedicine Research Laboratory, Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Telangana, India.
ORCID-Profile: Swati Biswas
Förderung
- Indian Council of Medical Research
Zitieren
APA
P S, S., Banerjee, T., Ghosh, B., & Biswas, S. (2026). Cancer Cell Membrane‐Coated Nanoparticles for Homotypic Targeting and Photothermal Chemo‐Immunomodulatory Therapy of Oral Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504519
Vancouver
P S S, Banerjee T, Ghosh B, Biswas S. Cancer Cell Membrane‐Coated Nanoparticles for Homotypic Targeting and Photothermal Chemo‐Immunomodulatory Therapy of Oral Cancer. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504519
BibTeX
@article{PS2026,
author = {P S, Shishira and Banerjee, Tonmoy and Ghosh, Balaram and Biswas, Swati},
title = {Cancer Cell Membrane‐Coated Nanoparticles for Homotypic Targeting and Photothermal Chemo‐Immunomodulatory Therapy of Oral Cancer},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504519}
}
EUVIMED